Advertisement

Topics

ES Cell International Party Limited Company Profile

16:51 EDT 19th September 2017 | BioPortfolio

ES Cell International Pte Ltd is a regenerative medicine company aiming to be a world leading provider of products and technologies derived from human embryonic stem (hES) cells.

ES Cell International controls significant platform technology due to its intellectual property and know-how in the area of hES cells and their directed differentiation.



ES Cell International is one of 10 groups whose hES cells are listed on the US National Institute of Health (NIH) Stem Cell Registry. This listing means that research partners who access ES Cell International's cells are eligible to apply for a share of $480 million (US) in funding.



ES Cell International has assembled a world-class research and management team to best capitalise on the opportunities derived from hES cell technology. The 7 strong management team is made up of authorities in their field with significant experience from around the world. The team includes a Director of Molecular and Genomic Discovery, based in Melbourne, and a Chief Scientific Officer based in Singapore.

Location

PO Box 6492
Melbourne
VIC
8008
Australia

Contact

Phone: +61 3 8532 1777
Fax: +61 3 8532 1771
Email: jschmitt@escellinternational.com


News Articles [2929 Associated News Articles listed on BioPortfolio]

International Stem Cell (ISCO) - Green light for second cohort

Edison Investment Research - Pharmaceutical & healthcare - International Stem Cell : International Stem Cell recently announced that the data safety monitoring board (DSMB) for its Phase I trial of IS...

International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson's Disease at the ASGCT 2017 Annual Meeting

CARLSBAD, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...

Novartis International AG: Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL

Novartis International AG / Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL . Processed and t...

Patient's immune status associated with outcome following third-generation CAR T-cell therapy

Treatment with third-generation CAR T–cell therapy led to a complete response in six of 15 patients with a CD19-positive B-cell malignancy and overall survival was associated with the patient's immu...

Novartis International AG: Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice

Novartis International AG / Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at...

'Natural born killer' cell discovery

An unexpected role for a white blood cell called the Natural Killer (NK) cell - a critical cell for ridding the body of infection and cancer, has been discovered by researchers at New Zealand's Univer...

M.E. debate scheduled to take place in the Scottish Parliament next Tuesday (May 9) | 5 May 2017

Motion S5M-05038: Gail Ross, Caithness, Sutherland and Ross, Scottish National Party, Date Lodged: 03/04/2017 12 May, International ME Day That the Parliament acknowledges that 12 May 2017 marks the i...

What does the ABPI think about the Labour Party manifesto?

The Labour Party 2017 General Election Manifesto has been launched today [Tuesday 16 May] in Bradford. 'For The Many, Not The Few' outlines the party’s vision for a Labour government under Jeremy Co...

PubMed Articles [8106 Associated PubMed Articles listed on BioPortfolio]

Voting on Embryonic Stem Cell Research: Citizens More Supportive than Politicians.

As the public debate over stem cell research continues, the observable voting behaviour in Switzerland offers a unique opportunity to compare the voting behaviour of politicians with that of voters. B...

The MARCH family joins the antigen cross-presentation party.

System dynamics research of remanufacturing closed-loop supply chain dominated by the third party.

With the rapid development of the electronic information industry in recent years, electronic products are being updated faster and faster, and e-waste recycling has become a common problem around the...

Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group.

Fertility preservation is an urgent challenge in the transplant setting. A panel of transplanters and fertility specialists within the Pediatric Diseases Working Party of the European Society for Bloo...

Prognostic Value of Tissue Based Biomarker Signature in Clear Cell Renal Cell Carcinoma.

To improve risk stratification for recurrence prognostication in localized clear cell renal cell carcinoma (ccRCC) patients.

Clinical Trials [6002 Associated Clinical Trials listed on BioPortfolio]

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

Primary Objective: 1. To determine the maximally tolerated dose of anti-third party cytolytic T-lymphocytes, defined as the dose which achieve engraftment without severe GVHD (graft-vs-h...

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

To assess the safety and biological efficacy of therapeutically administered most closely HLA-matched third party donor-derived specific cytotoxic T lymphocytes (CTLs) targeting cytomegalo...

Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that ar...

Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From A Normal HLA- Compatible Or Partially- Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

This study is testing to see how well transfusions of T-cells work in treating Epstein-Barr Virus (EBV). These T-cells are made from the blood of normal donors who are immune to EBV. A tra...

Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance

This study aims to learn about the needs and feelings of women who are infertile. Being infertile means not being able to have a child without the help of a third party. There are other op...

Companies [2477 Associated Companies listed on BioPortfolio]

ES Cell International Party Limited

ES Cell International Pte Ltd is a regenerative medicine company aiming to be a world leading provider of products and technologies derived from human embryonic stem (hES) cells. ES Cell International...

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty ...

Cryo-Cell International, Inc.

Based in Oldsmar, Florida, with over 200,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-C...

Party City

Party City Corporation is America's largest specialty party goods chain and the country's premier Halloween specialty retailer. Party City operates more than 600 company-owned and franchise stores thr...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "ES Cell International Party Limited" on BioPortfolio

We have published hundreds of ES Cell International Party Limited news stories on BioPortfolio along with dozens of ES Cell International Party Limited Clinical Trials and PubMed Articles about ES Cell International Party Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ES Cell International Party Limited Companies in our database. You can also find out about relevant ES Cell International Party Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record